R540,00
This is a liquid formulation which contains glucosamine sulphate and has a mild anti-inflammatory action due to free-radical scavenging and is believed to increase the production of hyaluronic acid – the major component of joint fluid.
3 in stock
Reg No. V 23134 Act/Wet 36/1947
CONTENTS:
Glucosamine sulphate 300 g/l equivalent to Glucosamine base – 187,5 mg/mℓ
This is a liquid formulation which contains glucosamine sulphate. Glucosamine is an aminomonosaccaride that functions in the body as the pre-cursor (building block) of the disaccharide unit in glycosaminoglycans (GAG-s). Dosing of glucosamine has been shown to have beneficial effects in arthritic cartilage by:
Stimulating the synthesis of proteoglycans and collagen by cartilage cells.
It has a mild anti-inflammatory action due to free-radical scavenging.
It is believed to increase the production of hyaluronic acid – the major component of joint fluid.
Glucosamine is highly bioavailable and has been demonstrated to be effective in the management of osteo-arthritis – which has been published in numerous controlled clinical trials.
The management of arthritis involves an integrated approach with adjustment of exercise level, diet and a variety of medications. Chondroprotective agents like RIGLY GLUCOSAMINE should be an integral part of arthritis management as they maximise the healing response of cartilage to help maintain normal joint structure and function for as long as possible.
